BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

333 related articles for article (PubMed ID: 20949263)

  • 1. Comparative oral bioavailability of non-fixed and fixed combinations of artesunate and amodiaquine in healthy Indian male volunteers.
    Fortin A; Verbeeck RK; Jansen FH
    Eur J Clin Pharmacol; 2011 Mar; 67(3):267-75. PubMed ID: 20949263
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Population pharmacokinetics of artesunate and amodiaquine in African children.
    Stepniewska K; Taylor W; Sirima SB; Ouedraogo EB; Ouedraogo A; Gansané A; Simpson JA; Morgan CC; White NJ; Kiechel JR
    Malar J; 2009 Aug; 8():200. PubMed ID: 19691851
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Tolerability and pharmacokinetics of non-fixed and fixed combinations of artesunate and amodiaquine in Malaysian healthy normal volunteers.
    Navaratnam V; Ramanathan S; Wahab MS; Siew Hua G; Mansor SM; Kiechel JR; Vaillant M; Taylor WR; Olliaro P
    Eur J Clin Pharmacol; 2009 Aug; 65(8):809-21. PubMed ID: 19404632
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Validation of high performance liquid chromatography-electrochemical detection methods with simultaneous extraction procedure for the determination of artesunate, dihydroartemisinin, amodiaquine and desethylamodiaquine in human plasma for application in clinical pharmacological studies of artesunate-amodiaquine drug combination.
    Lai CS; Nair NK; Muniandy A; Mansor SM; Olliaro PL; Navaratnam V
    J Chromatogr B Analyt Technol Biomed Life Sci; 2009 Feb; 877(5-6):558-62. PubMed ID: 19147417
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Bioavailability of a co-formulated combination of amodiaquine and artesunate under fed and fasted conditions. A randomised, open-label crossover study.
    Fitoussi S; Thang C; Lesauvage E; Barré J; Charron B; Filali-Ansary A; Lameyre V
    Arzneimittelforschung; 2009; 59(7):370-6. PubMed ID: 19728565
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pharmacokinetics and pharmacodynamics of a new ACT formulation: Artesunate/Amodiaquine (TRIMALACT) following oral administration in African malaria patients.
    Sinou V; Malaika LT; Taudon N; Lwango R; Alegre SS; Bertaux L; Sugnaux F; Parzy D; Benakis A
    Eur J Drug Metab Pharmacokinet; 2009; 34(3-4):133-42. PubMed ID: 20166428
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pharmacokinetic properties and bioequivalence of two sulfadoxine/pyrimethamine fixed-dose combination tablets: a parallel-design study in healthy Chinese male volunteers.
    Liu YM; Zhang KE; Liu Y; Zhang HC; Song YX; Pu HH; Lu C; Liu GY; Jia JY; Zheng QS; Zhu JM; Yu C
    Clin Ther; 2012 Nov; 34(11):2212-20. PubMed ID: 23084093
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pharmacokinetics of artemether-lumefantrine and artesunate-amodiaquine in children in Kampala, Uganda.
    Mwesigwa J; Parikh S; McGee B; German P; Drysdale T; Kalyango JN; Clark TD; Dorsey G; Lindegardh N; Annerberg A; Rosenthal PJ; Kamya MR; Aweeka F
    Antimicrob Agents Chemother; 2010 Jan; 54(1):52-9. PubMed ID: 19841149
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Application of an LC-MS/MS method for reliable determination of amodiaquine, N-desethylamodiaquine, artesunate and dihydroartemisinin in human plasma for a bioequivalence study in healthy Indian subjects.
    Rathod DM; Patel KR; Mistri HN; Jangid AG; Shrivastav PS; Sanyal M
    J Pharm Biomed Anal; 2016 May; 124():67-78. PubMed ID: 26930583
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pharmacokinetics and bioavailability comparison of generic and branded citalopram 20 mg tablets: an open-label, randomized-sequence, two-period crossover study in healthy Chinese CYP2C19 extensive metabolizers.
    Jiang T; Rong Z; Xu Y; Chen B; Xie Y; Chen C; Lu Y; Shen Y; Li H; Sun J; Chen H
    Clin Drug Investig; 2013 Jan; 33(1):1-9. PubMed ID: 23179471
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Bioequivalence of sitagliptin/metformin fixed-dose combination tablets and concomitant administration of sitagliptin and metformin in healthy adult subjects: a randomized, open-label, crossover study.
    Migoya EM; Miller JL; Gutierrez M; Zheng W; Johnson-Levonas AO; Liu Q; Matthews CZ; Wagner JA; Gottesdiener KM
    Clin Drug Investig; 2010; 30(12):855-66. PubMed ID: 20923244
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Therapeutic efficacy of artesunate-amodiaquine combinations and the plasma and saliva concentrations of desethylamodiaquine in children with acute uncomplicated Plasmodium falciparum malaria.
    Sowunmi A; Gbotosho GO; Happi CT; Okuboyejo TM; Sijuade AO; Michael OS; Adewoye EO; Folarin O
    Am J Ther; 2013 Jan; 20(1):48-56. PubMed ID: 21192244
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparative bioavailability and tolerability of a single 20-mg dose of two fluoxetine hydrochloride dispersible tablet formulations in fasting, healthy Chinese male volunteers: an open-label, randomized-sequence, two-period crossover study.
    Shi S; Liu Y; Wu J; Li Z; Zhao Y; Zhong D; Zeng F
    Clin Ther; 2010 Oct; 32(11):1977-86. PubMed ID: 21095492
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Validation and pharmacokinetic application of a high-performance liquid chromatographic technique for determining the concentrations of amodiaquine and its metabolite in plasma of patients treated with oral fixed-dose amodiaquine-artesunate combination in areas of malaria endemicity.
    Adedeji ON; Bolaji OO; Falade CO; Osonuga OA; Ademowo OG
    Antimicrob Agents Chemother; 2015 Sep; 59(9):5114-22. PubMed ID: 25896711
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Fixed dose artesunate amodiaquine - a phase IIb, randomized comparative trial with non-fixed artesunate amodiaquine.
    Ogutu B; Juma E; Obonyo C; Jullien V; Carn G; Vaillant M; Taylor WR; Kiechel JR
    Malar J; 2014 Dec; 13():498. PubMed ID: 25515698
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pharmacokinetic properties and bioequivalence of two formulations of arbidol: an open-label, single-dose, randomized-sequence, two-period crossover study in healthy Chinese male volunteers.
    Liu MY; Wang S; Yao WF; Wu HZ; Meng SN; Wei MJ
    Clin Ther; 2009 Apr; 31(4):784-92. PubMed ID: 19446151
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pharmacokinetic properties and bioequivalence of two compound formulations of 1500 mg ampicillin (1167 mg)/probenecid (333 mg): a randomized-sequence, single-dose, open-label, two-period crossover study in healthy Chinese male volunteers.
    Wu H; Liu M; Wang S; Feng W; Yao W; Zhao H; Wei M
    Clin Ther; 2010 Mar; 32(3):597-606. PubMed ID: 20399996
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Evaluation of two novel tablet formulations of artemether-lumefantrine (Coartem) for bioequivalence in a randomized, open-label, two-period study.
    Lefèvre G; Bhad P; Jain JP; Kalluri S; Cheng Y; Dave H; Stein DS
    Malar J; 2013 Sep; 12():312. PubMed ID: 24010572
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Bioequivalence and pharmacokinetic comparison of two mycophenolate mofetil formulations in healthy Chinese male volunteers: an open-label, randomized-sequence, single-dose, two-way crossover study.
    Zhang Q; Tao Y; Zhu Y; Zhu D
    Clin Ther; 2010 Jan; 32(1):171-8. PubMed ID: 20171422
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pharmacokinetics and tolerability of artesunate and amodiaquine alone and in combination in healthy volunteers.
    Orrell C; Little F; Smith P; Folb P; Taylor W; Olliaro P; Barnes KI
    Eur J Clin Pharmacol; 2008 Jul; 64(7):683-90. PubMed ID: 18415093
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.